Literature DB >> 17131365

Biophysical analysis of prototype microbicidal gels.

Derek H Owen1, Jennifer J Peters, Sarah L Kieweg, Anthony R Geonnotti, Roger L Schnaare, David F Katz.   

Abstract

The objective of this study was to evaluate the distribution and retention (deployment) of four prototype vehicles for delivery of prophylactic microbicides against vaginal HIV transmission. Study gels were created with different molecular compositions, producing different biophysical properties governing vaginal deployment. The study employed three techniques: direct rheological measurement of gel properties, direct observation of gel surface coating erosion, and dissolution by a vaginal fluid simulant, and mathematical modeling of gel squeezing flow processes. Results suggest significant differences in extent of vaginal coating after gel application and in erosion of these gel layers due to contact with ambient vaginal fluid and shearing. The relationships between gel rheological properties, coating flow and erosion of coating were not always anticipated from differences in gel molecular composition. 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Mesh:

Substances:

Year:  2007        PMID: 17131365     DOI: 10.1002/jps.20736

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

2.  Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel.

Authors:  Satheesh Podaralla; Carsten Alt; Gita N Shankar
Journal:  AAPS PharmSciTech       Date:  2014-04-30       Impact factor: 3.246

3.  Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel.

Authors:  Julie I Jay; Shetha Shukair; Kristofer Langheinrich; Melissa C Hanson; Gianguido C Cianci; Todd J Johnson; Meredith R Clark; Thomas J Hope; Patrick F Kiser
Journal:  Adv Funct Mater       Date:  2009-09-23       Impact factor: 18.808

4.  Poly(ethylene glycol) (PEG)-lactic acid nanocarrier-based degradable hydrogels for restoring the vaginal microenvironment.

Authors:  Sujata Sundara Rajan; Yevgeniy Turovskiy; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  J Control Release       Date:  2014-09-16       Impact factor: 9.776

5.  Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability.

Authors:  Stéphane Verguet; Bethany Young Holt; Andrew J Szeri
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

6.  Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.

Authors:  Sara J Whitehead; Catherine McLean; Supaporn Chaikummao; Sarah Braunstein; Wat Utaivoravit; Janneke H van de Wijgert; Philip A Mock; Taweesap Siraprapasiri; Barbara A Friedland; Peter H Kilmarx; Lauri E Markowitz
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

7.  Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.

Authors:  S A Shukair; S A Allen; G C Cianci; D J Stieh; M R Anderson; S M Baig; C J Gioia; E J Spongberg; S M Kauffman; M D McRaven; H Y Lakougna; C Hammond; P F Kiser; T J Hope
Journal:  Mucosal Immunol       Date:  2012-09-19       Impact factor: 7.313

8.  Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery.

Authors:  Gavin P Andrews; Louise Donnelly; David S Jones; Rhonda M Curran; Ryan J Morrow; A David Woolfson; R Karl Malcolm
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

9.  Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection.

Authors:  Joachim Brouwers; Kurt Vermeire; Dominique Schols; Patrick Augustijns
Journal:  Virology       Date:  2008-07-07       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.